Positive predictive value of device-detected atrial high-rate episodes at different rates and durations: An analysis from ASSERT

被引:131
|
作者
Kaufman, Elizabeth S. [1 ]
Israel, Carsten W. [2 ]
Nair, Girish M. [3 ]
Armaganijan, Luciana [4 ]
Divakaramenon, Syamkumar [3 ]
Mairesse, Georges H. [5 ]
Brandes, Axel [6 ]
Crystal, Eugene [7 ]
Costantini, Otto [1 ]
Sandhu, Roopinder K. [8 ]
Parkash, Ratika [9 ]
Connolly, Stuart J. [3 ]
Hohnloser, Stefan H. [10 ]
Healey, Jeff S. [3 ]
机构
[1] Case Western Reserve Univ, Heart & Vasc Res Ctr, Cleveland, OH 44109 USA
[2] Evangel Krankenhaus Bielefeld, Bielefeld, Germany
[3] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON, Canada
[4] Dante Pazzanese Inst Cardiol, Sao Paulo, Brazil
[5] Clin Sud Luxenbourg, Arlon, Belgium
[6] Odense Univ Hosp, DK-5000 Odense, Denmark
[7] Univ Toronto, Sunnybrook & Womens Hosp, Toronto, ON, Canada
[8] Univ Alberta, Edmonton, AB, Canada
[9] Dalhousie Univ, Halifax, NS, Canada
[10] Goethe Univ Frankfurt, Frankfurt, Germany
关键词
Atrial fibrillation; Pacemaker; Automatic detection; Atrial high-rate episode; Anticoagulation; Thromboembolic event; DIAGNOSTIC FEATURE; MODE SWITCH; FIBRILLATION; TACHYARRHYTHMIAS; ACCURACY; STROKE;
D O I
10.1016/j.hrthm.2012.03.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND Pacemakers can automatically identify and catalog atrial high-rate episodes (AHREs). While most AHREs represent true atrial tachyarrhythmia/atrial fibrillation (AT/AF), a review of stored electrograms suggests that a substantial proportion do not. As AHREs may lead to the initiation of oral anticoagulation, it is crucial to understand the relationship between AHREs and true AT/AF. OBJECTIVE To compare the positive predictive value of AHREs for electrogram-confirmed AT/AF for various atrial rates and episode durations. METHODS By using data from 2580 patients who participated in the ASymptomatic atrial fibrillation and Stroke Evaluation in pacemaker patients and the AF Reduction atrial pacing Trial, all AHREs >6 minutes and >190 beats/min with available electrograms were reviewed to determine whether they represented true AT/AF. The positive predictive value of these AHREs was assessed for episode durations of 6 minutes, 30 minutes, 6 hours, and 24 hours at atrial rates of 190 and 250 beats/min. RESULTS Of 5769 AHREs >6 minutes and >190 beats/min, 82.7% were true AT/AF and 17.3% were false positives (predominantly due to repetitive non-re-entrant ventriculoatrial synchrony). False positives dropped to 6.8%, 3.3%, and 1.8% when the threshold duration was increased to 30 minutes, 6 hours, and 24 hours, respectively. Increasing the threshold heart rate to 250 beats/min added little to the positive predictive value when longer threshold durations were used. CONCLUSIONS By using a cutoff of >6 minutes and >190 beats/min, the rate of false-positive AHREs is 17.3%, making physician review of electrograms essential. For AHREs lasting >6 hours, the rate of false positives is 3.3%, making physician review less crucial.
引用
收藏
页码:1241 / 1246
页数:6
相关论文
共 50 条
  • [41] Atrial High-Rate Episodes in Patients with Devices Without a History of Atrial Fibrillation: a Systematic Review and Meta-analysis
    Doundoulakis, Ioannis
    Gavriilaki, Maria
    Tsiachris, Dimitris
    Arsenos, Petros
    Antoniou, Christos-Konstantinos
    Dimou, Smaro
    Soulaidopoulos, Stergios
    Farmakis, Ioannis
    Akrivos, Evangelos
    Stoiloudis, Panagiotis
    Notas, Konstantinos
    Kimiskidis, Vasilios K.
    Giannakoulas, George
    Paraskevaidis, Stylianos
    Gatzoulis, Konstantinos A.
    Tsioufis, Konstantinos
    CARDIOVASCULAR DRUGS AND THERAPY, 2022, 36 (05) : 951 - 958
  • [42] Atrial High-Rate Episodes, Subclinical Atrial Fibrillation and Short-Duration Clinical Atrial Fibrillation: Different Names for the Same Arrhythmia or a New Player On the Pitch?
    Benezet-Mazuecos, Juan
    Lozano Rosado, Alvaro
    Crosa, Julian
    Antonio Iglesias, Jose
    JOURNAL OF THE SAUDI HEART ASSOCIATION, 2020, 32 (02) : 295 - 297
  • [43] The Differential Prognostic Impact of Long-Duration Atrial High-Rate Episodes Detected by Cardiac Implantable Electronic Devices between Patients with and without a History of Atrial Fibrillation
    Ishiguchi, Hironori
    Yoshiga, Yasuhiro
    Shimizu, Akihiko
    Ueyama, Takeshi
    Ono, Makoto
    Fukuda, Masakazu
    Kato, Takayoshi
    Fujii, Shohei
    Hisaoka, Masahiro
    Uchida, Tomoyuki
    Omuro, Takuya
    Okamura, Takayuki
    Kobayashi, Shigeki
    Yano, Masafumi
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [44] Relationship between predictive factors and atrial high-rate episodes in heart failure with reduced ejection fraction patients with cardiac implantable electronic devices
    Karaaslan, Ozge Cakmak
    Sahan, Ekrem
    Karanfil, Mustafa
    Guray, Umit
    ACTA CARDIOLOGICA, 2024,
  • [45] Optimal cut-off point of atrial high-rate episodes for prediction of stroke in japanese elderly patients with a cardiac implantable electronic device
    Kondo, Y.
    Nakano, M.
    Senoo, K.
    Nakano, M.
    Hayashi, T.
    Ito, R.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2018, 39 : 1311 - 1311
  • [46] Oral Anticoagulation in Device Patients With Atrial High-Rate Episodes: Shared Decision-Making After ARTESIA and NOAH-AFNET-6
    Albert, Christine M.
    CIRCULATION, 2024, 150 (18) : 1398 - 1400
  • [47] Role of atrial high-rate episodes in stratifying thromboembolic risk: a multiple cut-off diagnostic meta-analysis
    Saglietto, Andrea
    Ballatore, Andrea
    Brookles, Carola Griffith
    Xhakupi, Henri
    De Ferrari, Gaetano Maria
    Anselmino, Matteo
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2023, 10
  • [48] Atrial signal amplitude predicts atrial high-rate episodes in implantable cardioverter defibrillator patients: Insights from a large database of remote monitoring transmissions
    Zecchin, Massimo
    Solimene, Francesco
    D'Onofrio, Antonio
    Zanotto, Gabriele
    Iacopino, Saverio
    Pignalberi, Carlo
    Calvi, Valeria
    Maglia, Giampiero
    Della Bella, Paolo
    Quartieri, Fabio
    Curnis, Antonio
    Biffi, Mauro
    Capucci, Alessandro
    Caravati, Fabrizio
    Senatore, Gaetano
    Santamaria, Matteo
    Lissoni, Fabio
    Manzo, Michele
    Marini, Massimiliano
    Giammaria, Massimo
    Rapacciuolo, Antonio
    Sinagra, Gianfranco
    Giacopelli, Daniele
    Gargaro, Alessio
    Pisano, Ennio C.
    JOURNAL OF ARRHYTHMIA, 2020, 36 (02) : 353 - 362
  • [49] Effects of sodium-glucose cotransporter-2 inhibitor on atrial high-rate episodes in patients with cardiovascular implantable electronic device: a randomized controlled trial
    Nantsupawat, Teerapat
    Apaijai, Nattayaporn
    Phrommintikul, Arintaya
    Prasertwitayakij, Narawudt
    Chattipakorn, Siriporn C.
    Chattipakorn, Nipon
    Wongcharoen, Wanwarang
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [50] Device-detected atrial fibrillation and risk for stroke: an analysis of > 10 000 patients from the SOS AF project (Stroke preventiOn Strategies based on Atrial Fibrillation information from implanted devices)
    Boriani, Giuseppe
    Glotzer, Taya V.
    Santini, Massimo
    West, Teena M.
    De Melis, Mirko
    Sepsi, Milan
    Gasparini, Maurizio
    Lewalter, Thorsten
    Camm, John A.
    Singer, Daniel E.
    EUROPEAN HEART JOURNAL, 2014, 35 (08) : 508 - 516